Venova Medical has developed the VelocityTM pAVF System, a next generation percutaneous AVF technology designed to reduce the need for reinterventions to achieve fistula maturation, maintain functionality and improve vascular access outcomes while reducing costs....
Venova Medical will be attending the 2024 Charing Cross Symposium (CX) being held April 23-25,2024 in London, England. The meeting will feature a presentation by Robert Shahverdyan, MD, Head of Vascular Access Center at the Asklepios Klinik Barmbek in Hamburg,...
Venova Medical will be attending the 20th Annual Scientific Meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN) being held from February 23rd to 25th in New Orleans, Louisiana. Additionally, Robert Shahverdyan, MD, Head of Vascular...
Venova Medical will be attending the 2023 Charing Cross Symposium (CX). Contact us to arrange a meeting with a member of our team to learn more about the Velocity™ System and the company’s efforts. Meeting website:...
Venova Medical will be attending the 13th Congress of the Vascular Access Society. Contact us to arrange a meeting with a member of our team to learn more about the Velocity™ System and the company’s efforts. Meeting website: https://vas2023.com/...
